Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2011 Oct 8;33(1):184–196. doi: 10.1016/j.cct.2011.09.019

Table 5. Possible Study Medication Regimen.

Scenario 1 (No dose escalation) Scenario 2 (Dose escalation at step 3 only) Scenario 3 (Dose escalation at step 2 only) Scenario 4 (Dose escalation at step 2 and 3)
Step 1 Months 0-2 Solifenacin 5mg Solifenacin 5mg Solifenacin 5mg Solifenacin 5mg
Step 2 Months 3-4 Solifenacin 5mg Solifenacin 5mg Solifenacin 10mg Solifenacin 10mg
Step 3 Months 5-6 Solifenacin 5mg Solifenacin 10mg Solifenacin 10mg Trospium XR 60mg